Diagnosis, management and prevention of drug-induced liver injury.
about
Interaction of occupational and personal risk factors in workforce health and safetyDrug-Induced Liver Injury: Twenty Five Cases of Acute Hepatitis Following Ingestion of Polygonum multiflorum ThunbReal time identification of drug-induced liver injury (DILI) through daily screening of ALT results: a prospective pilot cohort studyLiver Function Test Abnormalities in Depressed Patients Treated with Antidepressants: A Real-World Systematic Observational Study in Psychiatric SettingsA systematic review of agomelatine-induced liver injuryStem cell-derived models to improve mechanistic understanding and prediction of human drug-induced liver injuryFatal case of sorafenib-associated idiosyncratic hepatotoxicity in the adjuvant treatment of a patient with renal cell carcinomaRelevance of Liver Failure for Anti-Infective Agents: From Pharmacokinetic Alterations to Dosage AdjustmentsWithholding statins in patients with underlying liver disease: wise or unwise?Assessment of liver fibrosis and associated risk factors in HIV-infected individuals using transient elastography and serum biomarkers.Characteristics and clinical outcome of nonsteroidal anti-inflammatory drug-induced acute hepato-nephrotoxicity among Chinese patientsAcute-on-chronic Liver Failure.Causes, Features, and Outcomes of Drug-Induced Liver Injury in 69 Children from China.'Les liaisons dangereuses': Hepatitis C, Rituximab and B-cell non-Hodgkin's lymphomas.Trial and error: investigational drug induced liver injury, a case series report.Population-representative Incidence of Acute-On-Chronic Liver Failure: A Prospective Cross-Sectional Study.Apoptosis and necrosis in the liverHuman skin-derived stem cells as a novel cell source for in vitro hepatotoxicity screening of pharmaceuticals.An Update on Drug-induced Liver Injury.A guide to the management of tuberculosis in patients with chronic liver disease.Psychotropic drugs and liver disease: A critical review of pharmacokinetics and liver toxicity.Predicting and preventing acute drug-induced liver injury: what's new in 2010?Clinical syndromes and consequences of antiretroviral-related hepatotoxicity.Alcoholic hepatitis: diagnosis and management in 2012.Risk of liver toxicity with the angiogenesis inhibitor pazopanib in cancer patients.Development of blood biomarkers for drug-induced liver injury: an evaluation of their potential for risk assessment and diagnostics.Idiosyncratic drug-induced liver injury: an update on the 2007 overview.Prescribing medications in patients with decompensated liver cirrhosis.Khat (Catha Edulis) as a possible cause of autoimmune hepatitis.Adverse Outcome Pathways and Drug-Induced Liver Injury Testing.Validity of diagnostic codes and laboratory measurements to identify patients with idiopathic acute liver injury in a hospital database.Pegvisomant-Induced Cholestatic Hepatitis in an Acromegalic Patient with UGT1A1 (⁎) 28 Mutation.Acute-on-chronic liver failure: terminology, mechanisms and management.Current challenges and controversies in drug-induced liver injury.Daclatasvir and Asunaprevir Combination Therapy-induced Hepatitis and Cholecystitis with Coagulation Disorder due to Hypersensitivity Reactions.Monocyte-derived hepatocyte-like cells for causality assessment of idiosyncratic drug-induced liver injury.Genetic Factors Influencing Drug-Induced Liver Injury: Do They Have a Role in Prevention and Diagnosis?Non-steroidal anti-inflammatory drugs: What is the actual risk of liver damage?Answers to multiple choice questions.Measures of BSEP Inhibition In Vitro Are Not Useful Predictors of DILI.
P2860
Q23919248-C1D394DF-40AC-4EA7-8627-4F98A03FC598Q24628066-0C295E8B-27CB-4F8A-809B-0083DB839976Q28482250-85C73B2F-0A4E-4953-A2A8-752EF6B1626AQ28552027-CAAE351A-D325-41A7-BB12-93282B7EFFBFQ28648515-27F9347D-4688-4F39-9864-D539BA1D30F2Q28818235-CC3323FA-BA2C-4ECC-9547-687B8EC29865Q31108636-FBC59A25-3947-4653-83B0-40AA7BB9A6CEQ33763177-B2508C3B-ECCE-415D-A578-9E3C903E3C46Q33763729-897A5B7D-CCBE-488C-8044-AFB3BD3648ACQ34209648-47E4B935-DD2F-4D09-93B3-D9C1F85C3462Q34326687-1B939F33-D4AD-4982-92CC-BA4A09B70862Q34542736-1FAEDD02-BD53-4438-AF82-04462B9594A1Q35771883-0A938C02-A6B1-45F3-860C-62E4C114052EQ35948807-D0E9D359-9BA1-47A2-9881-610025BDC979Q37150688-E3824CE2-53F2-468A-A76A-766E1161F5EBQ37162349-34D5CA8A-7AEC-4A69-86B9-C15416C8BB4BQ37403072-1DE86D2A-540A-4928-B07A-48FE0BC1BA4EQ37409080-5E815B19-BD9B-402D-871C-B2C4B416FEC5Q37613520-50BD082B-10C1-4E56-B14F-6EFCFC205667Q37613934-96F71E4D-0DB1-43CE-93C3-490D7DDE309FQ37625519-367E2985-CAFD-4C60-BFE7-22FC0FCD6E89Q37771029-55511D3E-C43A-4F0E-8245-29D074DBDF61Q37784777-30CF5018-E086-4CDE-AB0E-3DC4506D8068Q38067131-8F088EB8-6401-493D-8B82-E2B19553A3B0Q38099684-AFA7121A-0FFB-44C8-9EE4-4BB17B5791D1Q38122649-5E012C88-6987-429B-BD8F-C313B7D97CC1Q38145274-11FA8619-62C2-4244-B4F0-323EF8C52B0AQ38345809-4C586EB8-26D8-4422-9420-5268CCFFB4E6Q38350093-EBE83CA7-8F7A-41E2-8E5B-3C76C9C347ADQ38539524-F8CE6CCA-AAE5-4544-ADE4-DDA385E078B4Q38543135-B70497F3-A754-4F8D-AA05-9C43899FE3AAQ38591741-89D5E944-97C4-45BA-95F4-833A4CCB2012Q38720387-9BBF3737-52E1-4298-8386-171B28E27D7FQ39523252-D2483E50-74B4-4269-8111-F1CFDD44D8D7Q40076404-172B73D3-28D2-47DD-AD12-8EA3306CC085Q40867858-4E0C5EB8-796A-4FAF-827E-D921FA6C89C6Q41389082-F8BA24F4-F71F-4C47-A620-44D633805529Q42333984-357F0C8A-88AA-48E1-9C9F-9688C991CA4FQ42426062-28F8C991-39AA-4351-9E25-7731587C287BQ49615812-A194A0B1-7D17-41FB-9E16-815662903B72
P2860
Diagnosis, management and prevention of drug-induced liver injury.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Diagnosis, management and prevention of drug-induced liver injury.
@en
Diagnosis, management and prevention of drug-induced liver injury.
@nl
type
label
Diagnosis, management and prevention of drug-induced liver injury.
@en
Diagnosis, management and prevention of drug-induced liver injury.
@nl
prefLabel
Diagnosis, management and prevention of drug-induced liver injury.
@en
Diagnosis, management and prevention of drug-induced liver injury.
@nl
P356
P1433
P1476
Diagnosis, management and prevention of drug-induced liver injury.
@en
P2093
P304
P356
10.1136/GUT.2008.163675
P407
P577
2009-11-01T00:00:00Z